LogicBio Therapeutics (LOGC) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Cost of revenues: 241.9K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +82.6%
Financial Fact:
Cost of revenues: 241.9K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.23).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Barrington Research Starts CBIZ, Inc. (CBZ) at Outperform
- SEC probing popular type of private equity fund as it steps up industry scrutiny - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
